← FDA Drug Approvals (Drugs@FDA)

IMCIVREE

NDA · New Drug Application · Sponsor: RHYTHM · Approved 2020-11-25

Drug application

FDA Application #

NDA213793

Application type

New Drug Application

Brand name

IMCIVREE

Generic name

SETMELANOTIDE

Active ingredients

SETMELANOTIDE ACETATE

Dosage form

SOLUTION

Route

SUBCUTANEOUS

Marketing status

Prescription

Sponsor

RHYTHM

Manufacturer

Rhythm Pharmaceuticals, Inc

First approval

2020-11-25

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown